199 related articles for article (PubMed ID: 16999956)
1. Assessment of ovarian reserve by using the follicle-stimulating hormone isoform distribution pattern to predict the outcome of in vitro fertilization.
Letterie GS; Lee JS; Padmanabhan V
Fertil Steril; 2006 Nov; 86(5):1547-9. PubMed ID: 16999956
[TBL] [Abstract][Full Text] [Related]
2. Follicle-stimulating hormone isoforms are not useful as pretreatment predictors of outcome in in vitro fertilization: a pilot study.
Smeenk JM; Braat DD; Kremer JA; Sweep FC; Thomas CM
Fertil Steril; 2006 May; 85(5):1519-22. PubMed ID: 16579995
[TBL] [Abstract][Full Text] [Related]
3. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.
Smeenk JM; Sweep FC; Zielhuis GA; Kremer JA; Thomas CM; Braat DD
Fertil Steril; 2007 Jan; 87(1):223-6. PubMed ID: 17081531
[TBL] [Abstract][Full Text] [Related]
4. The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization.
Kwee J; Schats R; McDonnell J; Schoemaker J; Lambalk CB
Fertil Steril; 2006 Jun; 85(6):1714-22. PubMed ID: 16650416
[TBL] [Abstract][Full Text] [Related]
5. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
Barad DH; Weghofer A; Gleicher N
Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
[TBL] [Abstract][Full Text] [Related]
6. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening.
Jain T; Soules MR; Collins JA
Fertil Steril; 2004 Jul; 82(1):180-5. PubMed ID: 15237009
[TBL] [Abstract][Full Text] [Related]
7. Is granulocyte colony-stimulating factor level predictive for human IVF outcome?
Salmassi A; Schmutzler AG; Schaefer S; Koch K; Hedderich J; Jonat W; Mettler L
Hum Reprod; 2005 Sep; 20(9):2434-40. PubMed ID: 15890733
[TBL] [Abstract][Full Text] [Related]
8. Modest follicle-stimulating hormone elevations in younger women: warn but don't disqualify.
Toner JP
Fertil Steril; 2004 Jun; 81(6):1493-5; discussion 496-7. PubMed ID: 15193465
[TBL] [Abstract][Full Text] [Related]
9. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
10. Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization.
Altmäe S; Haller K; Peters M; Hovatta O; Stavreus-Evers A; Karro H; Metspalu A; Salumets A
Mol Hum Reprod; 2007 Aug; 13(8):521-6. PubMed ID: 17540666
[TBL] [Abstract][Full Text] [Related]
11. Random anti-Müllerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels.
Buyuk E; Seifer DB; Younger J; Grazi RV; Lieman H
Fertil Steril; 2011 Jun; 95(7):2369-72. PubMed ID: 21497340
[TBL] [Abstract][Full Text] [Related]
12. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
Orvieto R; Meltzer S; Rabinson J; Gemer O; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
[TBL] [Abstract][Full Text] [Related]
13. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.
Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Fauser BC; Broekmans FJ
Hum Reprod; 2007 Jul; 22(7):1919-24. PubMed ID: 17485438
[TBL] [Abstract][Full Text] [Related]
14. Basal and cycle androgen levels correlate with in vitro fertilization stimulation parameters but do not predict pregnancy outcome.
Frattarelli JL; Gerber MD
Fertil Steril; 2006 Jul; 86(1):51-7. PubMed ID: 16716312
[TBL] [Abstract][Full Text] [Related]
15. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
[TBL] [Abstract][Full Text] [Related]
16. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth.
Meirow D; Levron J; Eldar-Geva T; Hardan I; Fridman E; Yemini Z; Dor J
Fertil Steril; 2007 Feb; 87(2):418.e7-418.e15. PubMed ID: 17097653
[TBL] [Abstract][Full Text] [Related]
18. The forgotten variable: impact of luteinizing hormone on the prediction of ovarian reserve.
Weghofer A; Feichtinger W
Fertil Steril; 2006 Jan; 85(1):259-61. PubMed ID: 16412772
[TBL] [Abstract][Full Text] [Related]
19. Predicting poor ovarian response in IVF: use of repeat basal FSH measurement.
Bancsi LF; Broekmans FJ; Looman CW; Habbema JD; te Velde ER
J Reprod Med; 2004 Mar; 49(3):187-94. PubMed ID: 15098888
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
McIlveen M; Skull JD; Ledger WL
Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
